Cases & Deals

Celularity raises capital in Series A round

Clients Celularity, Inc.

Jones Day represented Celularity Inc., a biotechnology company that sources and develops transformative therapies derived from the placenta, in connection with its issuance of Series A Convertible Preferred Stock in a private placement to strategic and entrepreneurial investors.